Media Summary: Presented By: Jenna Frame Speaker Biography: Dr. Jenna Frame has worked with multiple strains of In this webinar, Kaya Gosh, Ph.D., and Cat Chappell, M.S. discuss the most widely used Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent

Immunodeficient Mouse Models To Support - Detailed Analysis & Overview

Presented By: Jenna Frame Speaker Biography: Dr. Jenna Frame has worked with multiple strains of In this webinar, Kaya Gosh, Ph.D., and Cat Chappell, M.S. discuss the most widely used Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent Speakers: Dr. Santi Suryani Chen, Associate Director of Immunology and Oncology Dr. Zhiying Li, Directory of Life Science and ... Alexander Michels, Paul-Ehrlich-Institut, Langen, Germany, provides an overview of Federica Benvenuti, ICGEB, Trieste - Italy speaks on "

Juliane Mietz, University Of Zurich, Zurich, Switzerland, describes Join Rick Huntress and Natalie Hurlen, Ph.D. on Wednesday, August 12 as they discuss humanizing The Jackson Laboratory offers more than 7000 genetically defined strains of JAX® Presented at Cancer Research & Oncology 2017: Lee ... November 17, 2020 - Would you like to learn about housing and health considerations related to Speaker: Dr. Jim Jin Dr. Jin received his Ph.D. from Louisiana State University in immunology and infectious diseases. He has ...

December 7, 2021 Speaker: Steve Smith, PhD Approximately 7% -9% of the global population suffers from autoimmune diseases. Innate Immunotherapy Responses in Mouse and Humanized Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to ... Translational challenges in immunotherapy impede the successful transition of many therapeutic candidates to the clinic. Speaker: Dr. Juan Hong, Business Development Manager of International Department at Shanghai

Photo Gallery

Immunodeficient Mouse Models to Support Prolonged Engraftment of Human NK and Tumor Cells
Comparing Immunodeficient Models for Cancer, Immunity, and Transplant Research
JAX LIVE! T-cells, B-cells, macrophages: how to pick immunodeficient models
[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 2nd)
Comparing mouse models for the study of immunotherapies
F. Benvenuti - Mouse models in immunology studies
Human Mouse Models to Study Interactions Between Beta Cells and The Immune System
Research in Anti-Cancer Immunology: How to Utilize Mouse Models and Human Tissue in Cancer Research
Assessing existing pre-clinical mouse models for immunotherapies
Part 2 of a 3-part Humanized Mouse Series: What to Consider When Humanizing an Immunodeficient Mouse
Humanized Mouse Models for Biomedical Research: Selection and Experimental Implications
Characterization and application of the triple immunodeficient R2G2 mouse model
Sponsored
Sponsored
View Detailed Profile
Immunodeficient Mouse Models to Support Prolonged Engraftment of Human NK and Tumor Cells

Immunodeficient Mouse Models to Support Prolonged Engraftment of Human NK and Tumor Cells

Presented By: Jenna Frame Speaker Biography: Dr. Jenna Frame has worked with multiple strains of

Comparing Immunodeficient Models for Cancer, Immunity, and Transplant Research

Comparing Immunodeficient Models for Cancer, Immunity, and Transplant Research

In this webinar, Kaya Gosh, Ph.D., and Cat Chappell, M.S. discuss the most widely used

Sponsored
JAX LIVE! T-cells, B-cells, macrophages: how to pick immunodeficient models

JAX LIVE! T-cells, B-cells, macrophages: how to pick immunodeficient models

Join Grace Berryhill, Ph.D. and Andrew Schile, Ph.D. as they discuss the considerations in choosing an immunodeficent

[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 2nd)

[Webinar] Immunodeficient Mouse Models for Cancer & Immunotherapy Research: NCG Mice (20220426 2nd)

Speakers: Dr. Santi Suryani Chen, Associate Director of Immunology and Oncology Dr. Zhiying Li, Directory of Life Science and ...

Comparing mouse models for the study of immunotherapies

Comparing mouse models for the study of immunotherapies

Alexander Michels, Paul-Ehrlich-Institut, Langen, Germany, provides an overview of

Sponsored
F. Benvenuti - Mouse models in immunology studies

F. Benvenuti - Mouse models in immunology studies

Federica Benvenuti, ICGEB, Trieste - Italy speaks on "

Human Mouse Models to Study Interactions Between Beta Cells and The Immune System

Human Mouse Models to Study Interactions Between Beta Cells and The Immune System

March 1, 2023 "Human

Research in Anti-Cancer Immunology: How to Utilize Mouse Models and Human Tissue in Cancer Research

Research in Anti-Cancer Immunology: How to Utilize Mouse Models and Human Tissue in Cancer Research

May 30, 2017: Marcus Bosenberg, MD, PhD.

Assessing existing pre-clinical mouse models for immunotherapies

Assessing existing pre-clinical mouse models for immunotherapies

Juliane Mietz, University Of Zurich, Zurich, Switzerland, describes

Part 2 of a 3-part Humanized Mouse Series: What to Consider When Humanizing an Immunodeficient Mouse

Part 2 of a 3-part Humanized Mouse Series: What to Consider When Humanizing an Immunodeficient Mouse

Join Rick Huntress and Natalie Hurlen, Ph.D. on Wednesday, August 12 as they discuss humanizing

Humanized Mouse Models for Biomedical Research: Selection and Experimental Implications

Humanized Mouse Models for Biomedical Research: Selection and Experimental Implications

The Jackson Laboratory offers more than 7000 genetically defined strains of JAX®

Characterization and application of the triple immunodeficient R2G2 mouse model

Characterization and application of the triple immunodeficient R2G2 mouse model

Presented at Cancer Research & Oncology 2017: https://www.labroots.com/virtual-event/cancer-research-oncology-2017 Lee ...

MiceTech Talk Episode 24: Let's Talk Caring for Immunodeficient Mice (17-Nov-2020)

MiceTech Talk Episode 24: Let's Talk Caring for Immunodeficient Mice (17-Nov-2020)

November 17, 2020 - Would you like to learn about housing and health considerations related to

Webinar: Next-Generation B-NDG Mice: Improved Immunodeficient Models for Research and Discovery

Webinar: Next-Generation B-NDG Mice: Improved Immunodeficient Models for Research and Discovery

We introduced Biocytogen's highly

Humanized M NSG PBMC and CD34+ Mouse Models 2023 | Applied StemCell, Inc.

Humanized M NSG PBMC and CD34+ Mouse Models 2023 | Applied StemCell, Inc.

Speaker: Dr. Jim Jin Dr. Jin received his Ph.D. from Louisiana State University in immunology and infectious diseases. He has ...

Humanized Mouse Model Options for Autoimmune Diseases

Humanized Mouse Model Options for Autoimmune Diseases

December 7, 2021 Speaker: Steve Smith, PhD Approximately 7% -9% of the global population suffers from autoimmune diseases.

Innate Immunotherapy Responses in Mouse and Humanized Mouse Models

Innate Immunotherapy Responses in Mouse and Humanized Mouse Models

Innate Immunotherapy Responses in Mouse and Humanized

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models

Since the first immune checkpoint blocker ipilimumab was approved by the US FDA in 2011, more drug companies have sought to ...

Advancing T cell Therapies Using B-hCD3 Mouse Models

Advancing T cell Therapies Using B-hCD3 Mouse Models

Translational challenges in immunotherapy impede the successful transition of many therapeutic candidates to the clinic.

SMOC Humanized Mouse Models for Immunotherapies of Cancer

SMOC Humanized Mouse Models for Immunotherapies of Cancer

Speaker: Dr. Juan Hong, Business Development Manager of International Department at Shanghai